Neoantigens is a class of HLA-bound peptides that arise from tumor-specific mutations. They are highly immunogenic because they are not present in normal tissues, thus can be used as biomarkers differentiating cancer cells from normal cells. It has been shown that recognition of these individual-specific neoantigens opens a new door for cancer immunotherapy. https://www.creative-peptides.com/services/neoantigen-peptides-vaccine-service.html
Cancer ResearchDrug DiscoveryMolecular BiologyPersonalized Medicine